Cellares

Executive Summary

Cellares is pioneering the Integrated Development and Manufacturing Organization (IDMO) model, applying Industry 4.0 principles to mass-produce cell therapies. By integrating development and manufacturing into a single, automated platform, the company aims to address critical bottlenecks in cell therapy production, reducing costs and improving access to life-saving treatments. Based in South San Francisco, Cellares leverages robotics, data analytics, and modular system design to enable scalable, reproducible manufacturing. With a pre-clinical stage focus, the company is positioning itself as a key enabler for the cell therapy ecosystem, targeting partnerships with biotech firms to accelerate therapeutic timelines and lower failure rates.

Upcoming Catalysts (preview)

• Q3 2026Series C or Major Funding Round70% success
• Q4 2026First Partnership with a Cell Therapy Developer60% success
• TBDRegulatory Filing for Manufacturing Platform (e.g., IND support)40% success